InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,005.48
(
0.54%
)
US TECH 100
20,582.00
(
0.20%
)
Dow Jones
44,053.93
(
0.74%
)
Brent Oil
73.72
(
-2.31%
)
Bitcoin
77,014.50
(
1.47%
)
Post# of 253559
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 839
Posts 120694
Boards Moderated 14
Alias Born 09/05/2002

DewDiligence

Member Level

Re: apljack post# 190897

Thursday, 06/18/2015 1:51:16 PM

Thursday, June 18, 2015 1:51:16 PM

Post# of 253559
NXTM cites study showing home hemodialysis has 2x survival compared to (home) peritoneal dialysis:

http://finance.yahoo.com/news/study-finds-home-hemodialysis-patient-122200463.html

I’d bet that BAX (the world leader in peritoneal dialysis) has studies it could cite to rebut NXTM.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up